Sort by
Refine Your Search
-
mortality and drives therapy resistance. Yet, clinical management of cancer cachexia is far from satisfactory, with no approved drugs for this indication. Microbiota-based therapies have the potential
-
the European Marie Skłodowska-Curie Actions (MSCA) Doctoral Network “B-ACTIVE”. The position is 36 months and funded by the European Union’s Horizon Europe Research and Innovation programme under the grant
-
. The fellowship is part of the European Marie Skłodowska-Curie Actions (MSCA) Doctoral Network “B-ACTIVE”. The position is 36 months and funded by the European Union’s Horizon Europe Research and Innovation
-
, innovation and scientific advice. We offer a rewarding and challenging job in an international environment. We strive for academic excellence in an environment characterized by collegial respect and academic
-
project at DTU Health Tech, driving innovation in infectious therapy through advanced drug delivery systems. Optimize formulations, conduct experiments, and contribute to commercialization. PhD in relevant
-
(MSCA) Doctoral Network “B-ACTIVE”. The position is 36 months and funded by the European Union’s Horizon Europe Research and Innovation programme under the grant agreement No 101120187, acronym B-ACTIVE